October 2024, saw significant FDA actions and clinical trial updates that shaped cancer treatment progress. Highlights include acalabrutinib’s approval for mantle cell lymphoma, T-DXd’s priority ...
Okpebholo’s media aide, Godspower Inegbe, stated that Edo residents are increasingly worried about Obaseki’s reckless remarks ...